Atlas Trials

A Phase I Trial of Simmitinib in Advanced Solid Tumors

Clinical trial NCT04058587 · UNKNOWN

Trial details

NCT number
NCT04058587
Sponsor
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Solid Tumor
Start date
2020-06-08
Primary completion
2023-01-31
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.